US2016262633A1PendingUtilityA1
Device and method for screening congenital heart disease
Assignee: LOS ANGELES BIOMEDICAL RES INST AT HARBOR-UCLA MEDICAL CENTERPriority: Jul 6, 2006Filed: May 24, 2016Published: Sep 15, 2016
Est. expiryJul 6, 2026(expired)· nominal 20-yr term from priority
Inventors:Ruey-Kang Chang
A61B 5/14551A61B 5/0205A61B 2562/222A61B 2560/0412A61B 7/026A61B 5/6823A61B 5/7282A61B 5/6841A61B 5/742A61B 5/6829A61B 7/02A61B 2503/045G16H 15/00G16H 50/30A61B 5/282
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described are congenital heart disease monitors. The monitors can include one or more processing units configured to receive multiple signals, wherein the multiple signals can include a first signal from a pulse oximetry sensor; and at least one additional signal from a sensor at another body region for screening for congenital heart disease. In embodiments, the first signal and the at least one additional signal can be used to detect a presence of congenital heart disease.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A congenital heart disease monitor comprising:
one or more processing units configured to receive multiple signals, wherein the multiple signals include:
a first signal from a pulse oximetry sensor; and
at least one additional signal from a sensor at another body region for screening for congenital heart disease;
wherein the first signal and the at least one additional signal are used to detect a presence of congenital heart disease.
2 . The congenital heart disease monitor of claim 1 , wherein the pulse oximetry sensor is located on a toe.
3 . The congenital heart disease monitor of claim 1 , wherein another body region deemed suitable for screening for congenital heart disease is on a patient's frontal plane.
4 . The congenital heart disease monitor of claim 1 , wherein the pulse oximetry sensor is located on a limb.
5 . The congenital heart disease monitor of claim 1 , wherein the pulse oximetry sensor is an LNOP sensor.
6 . The congenital heart disease monitor of claim 1 , wherein the pulse oximetry sensor is included in a probe.
7 . The congenital heart disease monitor of claim 1 , wherein the probe is configured to hold the pulse oximetry sensor against a body region.
8 . The congenital heart disease monitor of claim 1 , wherein the first signal and the at least one additional signal are screened for detected oxygen saturation.
9 . The congenital heart disease monitor of claim 1 , wherein the at least one additional signal is from a pulse oximetry sensor, an ECG, or a phonocardiogram.
10 . The congenital heart disease monitor of claim 1 , wherein congenital heart disease exists when an oxygen saturation level is less than 95%.
11 . A method of detecting congenital heart disease using a congenital heart disease monitor, the method comprising:
collecting multiple signals provided by the congenital heart disease monitor, wherein the multiple signals include:
a first signal from a pulse oximetry sensor; and
at least one additional signal from a sensor at another body region for screening for congenital heart disease;
using the collected signals to determine when a newborn has congenital heart disease when a reading of an oxygen saturation level less than 95%.
12 . The method of claim 11 , wherein another body region suitable for screening for congenital heart disease is on a frontal plane of the newborn.
13 . The method of claim 11 , wherein the pulse oximetry sensor is an LNOP sensor.
14 . The method of claim 11 , wherein the pulse oximetry sensor is located on a toe.
15 . The method of claim 11 , wherein the comparing is performed using an algorithm on one or more processing units configured to receive the multiple signals.
16 . The method of claim 11 , wherein the at least one additional signal is from another pulse oximetry sensor.
17 . The method of claim 11 , wherein the first signal and the at least one additional signal are screened for detected oxygen saturation.
18 . The method of claim 11 , wherein the at least one additional signal is from a pulse oximetry sensor, an ECG, or a phonocardiogram.
19 . The congenital heart disease monitor of claim 1 , wherein the congenital heart disease monitor includes a display.
20 . A congenital heart disease monitor comprising:
one or more processing units configured to receive multiple signals, wherein the multiple signals include:
a first signal from a pulse oximetry sensor located on a toe of a newborn; and
at least one additional signal from a sensor at another body region;
wherein the first signal and the at least one additional signal are used to determine if an oxygen saturation level is less than 95% of normal oxygen saturation levels.Join the waitlist — get patent alerts
Track US2016262633A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.